MediPharm Labs Corp. (OTCMKTS:MEDIF) Short Interest Down 44.0% in December

MediPharm Labs Corp. (OTCMKTS:MEDIF) was the target of a significant drop in short interest in the month of December. As of December 15th, there was short interest totaling 62,429 shares, a drop of 44.0% from the November 30th total of 111,394 shares. Based on an average daily volume of 166,101 shares, the days-to-cover ratio is presently 0.4 days. Based on an average daily volume of 166,101 shares, the days-to-cover ratio is presently 0.4 days.

MediPharm Labs Stock Down 1.6%

Shares of MEDIF stock traded down $0.00 on Friday, reaching $0.05. 81,823 shares of the company were exchanged, compared to its average volume of 142,933. MediPharm Labs has a 1 year low of $0.04 and a 1 year high of $0.09. The business has a 50-day moving average price of $0.05 and a 200 day moving average price of $0.05.

About MediPharm Labs

MediPharm Labs Corporation is a Canada-based company focused on the extraction, formulation and manufacturing of pharmaceutical-grade cannabis products. Through proprietary processes and a GMP-compliant facility in Mississauga, Ontario, the company produces high-purity distillates, isolates and advanced formulations tailored to both medical and adult-use markets.

The company’s core offerings include THC and CBD distillates, crystalline isolates, softgel capsules, oral thin films and sterile injectable products.